Abstract
Atherosclerosis is characterized by chronic inflammation of the vascular wall. Macrophages, which differentiate from circulating monocytes, give rise to foam cells by excessive accumulation of modified lipoproteins. Atherogenesis subsequently progresses through necrotic core expansion associated with apoptosis and the suppressed clearance of apoptotic macrophage (i.e. efferocytosis), followed by the transition to vulnerable plaques. The vulnerable plaque is characterized by thinning of the fibrous cap and necrotic core expansion. Here, the impact of monocytes/macrophages in both early atherogenesis and advanced plaque progression is discussed with a focus on the potential targeting of inflammatory processes in atherosclerosis.
Keywords: Atherosclerosis, inflammation, vulnerable plaque, chemokines, cytokines, oxidative stress, macrophages, lipoproteins, efferocytosis, fibrous cap
Current Pharmaceutical Design
Title:Novel Strategies to Target Inflammatory Processes in Atherosclerosis
Volume: 19 Issue: 9
Author(s): Toshio Imanishi and Takashi Akasaka
Affiliation:
Keywords: Atherosclerosis, inflammation, vulnerable plaque, chemokines, cytokines, oxidative stress, macrophages, lipoproteins, efferocytosis, fibrous cap
Abstract: Atherosclerosis is characterized by chronic inflammation of the vascular wall. Macrophages, which differentiate from circulating monocytes, give rise to foam cells by excessive accumulation of modified lipoproteins. Atherogenesis subsequently progresses through necrotic core expansion associated with apoptosis and the suppressed clearance of apoptotic macrophage (i.e. efferocytosis), followed by the transition to vulnerable plaques. The vulnerable plaque is characterized by thinning of the fibrous cap and necrotic core expansion. Here, the impact of monocytes/macrophages in both early atherogenesis and advanced plaque progression is discussed with a focus on the potential targeting of inflammatory processes in atherosclerosis.
Export Options
About this article
Cite this article as:
Imanishi Toshio and Akasaka Takashi, Novel Strategies to Target Inflammatory Processes in Atherosclerosis, Current Pharmaceutical Design 2013; 19 (9) . https://dx.doi.org/10.2174/1381612811319090009
DOI https://dx.doi.org/10.2174/1381612811319090009 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cutaneous Metabolism in Transdermal Drug Delivery
Current Drug Metabolism The Interleukin-1 System: An Attractive and Viable Therapeutic Target in Neurodegenerative Disease
Current Drug Targets - CNS & Neurological Disorders Respiratory Failure in Cancer Patients: Non-Infectious Complications of Antineoplastic Agents for Solid Tumors
Current Respiratory Medicine Reviews Regulation of the DNA Damage Response to DSBs by Post-Translational Modifications
Current Genomics Connexins, Diabetes and the Metabolic Syndrome
Current Protein & Peptide Science Targeting Inflammation in Primary Cardiovascular Prevention
Current Pharmaceutical Design Association of Zinc and Copper Status with Cardiovascular Diseases and their Assessment Methods: A Review Study
Mini-Reviews in Medicinal Chemistry Oncolytic Adenovirus: Preclinical and Clinical Studies in Patients with Human Malignant Gliomas
Current Gene Therapy Proteolytic Events of HIV-1 Replication as Targets for Therapeutic Intervention
Current Pharmaceutical Design Using Small Molecule GSK3β Inhibitors to Treat Inflammation
Current Medicinal Chemistry Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse
Current HIV Research GLUT4 Goes Abnormal: Disregulation of the Insulin-Responsive Glucose Transporter in Abnormal Metabolic States
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Recent Developments in the Field of Quinazoline Chemistry
Current Organic Chemistry The Therapeutic Target Hsp90 and Cancer Hallmarks
Current Pharmaceutical Design Puerarin: A Review on the Pharmacological Activity, Chemical Properties and Pharmacokinetics of Main Isoflavonoid
The Natural Products Journal Changes in Serum Markers of Inflammation and Endothelial Activation in HIV-Infected Antiretroviral Naive Patients Starting A Treatment with Abacavir-Lamivudine or Tenofovir-Emtricitabine Plus Efavirenz
Current HIV Research The Role of ABC Transporters in Drug Resistance, Metabolism and Toxicity
Current Drug Delivery Hallucinations Associated with Topiramate Therapy: A Case Report and Review of the Literature
Current Drug Safety Nongenomic Actions of Thyroid Hormones: From Basic Research to Clinical Applications. An Update
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development)
Current Pharmaceutical Design